Literature DB >> 8486144

Elimination of cefmenoxime during continuous haemofiltration.

J Evers1, K Borner, P Koeppe.   

Abstract

The elimination of cefmenoxime after single and repeated i.v. dosing was studied in 12 patients with severe renal failure and sepsis during continuous haemofiltration. More than 30% of the drug was found in the filtrate. The sieving coefficient (S) was 0.54. Vss% was unchanged 0.31 l.kg-1 in comparison with patients with normal renal function, whereas the mean t1/2ss was prolonged to about 16 h, and total clearance was reduced 20.8 ml.min-1.1.73 m-2. Once daily administration of 1 g cefmenoxime is suggested as the appropriate dose under such circumstances.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486144     DOI: 10.1007/bf01428389

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  2 in total

1.  Determination of cefmenoxime in human body fluids by high-performance liquid chromatography.

Authors:  K Borner; E Borner; H Lode; A Peters
Journal:  Eur J Clin Microbiol       Date:  1983-02       Impact factor: 3.267

2.  Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.

Authors:  J G Gambertoglio; D P Alexander; S L Barriere
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

  2 in total
  1 in total

1.  Cefotiam during continuous haemofiltration.

Authors:  J Evers; K Borner; P Koeppe
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.